0000921895-22-000661.txt : 20220224
0000921895-22-000661.hdr.sgml : 20220224
20220224201341
ACCESSION NUMBER: 0000921895-22-000661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giordano Natasha
CENTRAL INDEX KEY: 0001315585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36351
FILM NUMBER: 22673817
MAIL ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLx Pharma Inc.
CENTRAL INDEX KEY: 0001497504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271707962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
BUSINESS PHONE: (713) 842-1249
MAIL ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20140313
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20100726
4
1
form411577gio_02242022.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-22
0
0001497504
PLx Pharma Inc.
PLXP
0001315585
Giordano Natasha
9 FISHERS LANE
SUITE E
SPARTA
NJ
07871
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
4.99
2022-02-22
4
A
0
300000
0
A
2032-02-22
Common Stock
300000
300000
D
Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.
/s/ Natasha Giordano
2022-02-23